Nat. Rev. Rheumatol. 11, 415–429 (2015); published online 28 April 2015; doi:10.1038/nrrheum.2015.53
In Figure 2a of this Review, full protection against CIA was incorrectly stated as an effect of IL-17 deficiency instead of IL-17RA deficiency.
Additional information
The online version of the original article can be found at 10.1038/nrrheum.2015.53
Rights and permissions
About this article
Cite this article
Lubberts, E. Erratum: The IL-23–IL-17 axis in inflammatory arthritis. Nat Rev Rheumatol 11, 562 (2015). https://doi.org/10.1038/nrrheum.2015.128
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2015.128
This article is cited by
-
Bibliometric analysis on the structure and function of IL17
Egyptian Rheumatology and Rehabilitation (2024)
-
The Role of Early Treatment in the Management of Axial Spondyloarthritis: Challenges and Opportunities
Rheumatology and Therapy (2024)
-
The star target in SLE: IL-17
Inflammation Research (2023)
-
Shared genetic risk factors and causal association between psoriasis and coronary artery disease
Nature Communications (2022)
-
Anti-IL-23 exerted protective effects on cerebral ischemia–reperfusion injury through JAK2/STAT3 signaling pathway
Molecular Biology Reports (2021)
